Stock screenerAll disclosures →
EDGAR →
CRVO
Conviction 0HealthcareScan · Mon, Aug 10, 2026CRVO$2.86-0.35%
ResistanceSupportVol 14Vol MA14 322.05K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.86
Change-0.35%
Gap-1.05%
Rel volume0.62×
Avg volume449.65K
Avg $ vol1.29M
SMA 202.78
SMA 503.09
SMA 2005.07
Price vs 50-7.29%
Price vs 200-43.58%
MA stackbearish
50/200 cross—
Supertrenddown · 3.34
RSI (14)48
MACD hist0.04
MACD crossbull · 3d
Stoch %K / %D81 / 69
ADX (14)30
+DI / −DI26 / 20
RSI divergence—
MACD divergence—
ATR %+9.56%
ADR %7.35%
52w high10.69
52w low2.25
From 52w high-73.25%
Above 52w low+27.11%
New 52w highNo
SqueezeOn · 2d
Bollinger width27.67%
%B0.60
Donchian pos47.78%
Donchian high3.33
Donchian low2.43
AVWAP (52w high)4.95
vs AVWAP high-42.27%
AVWAP (52w low)4.87
vs AVWAP low-41.32%
OBV trendDown
Chaikin MF (20)-0.06
Today vs 20d0.62×
Avg vol (14d)322.05K
Avg vol (20d)449.65K
Avg $ vol (20d)1.29M
Market cap43.24M
RS 3m (vs SPY)-30.17%
RS 6m (vs SPY)-51.72%
RS line new highNo
Trend template0/8
Technical rank12.4
1 week+10.00%
1 month-19.89%
3 months-27.59%
6 months-46.14%
1 year-69.38%
YTD-63.29%
P/E-1.60
P/B1.88
P/S10.79
P/FCF-1.81
EPS2,038,891.00
Div yield—
ROE-117.45%
ROA-103.75%
Debt/Eq0.00
Current5.58
EV/EBITDA-0.74
Gross margin-43.38%
Net margin-673.06%
Rev growth-58.86%
EPS growth-65.53%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value20.83M
Revenue0
Net income-6.57M
Gross profit0
Free cash flow-23.9M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out9.26M
Employees15
ListedTue, Jun 18, 1996
Free float5.89M
Float %63.7%
Short interest827.46K
Days to cover1.0d
Short volume44.1%
Squeeze score36 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank12.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.87
Support2.51
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CRVO
No recent disclosed trades by Congress in CRVO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CRVO · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Gregoire Sylvie Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
BOGER JOSHUA S Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Hollingsworth Jane H Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Quigley David Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
ZAVRL FRANK Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Sabbagh Marwan Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
ALAM JOHN J CEO & President · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
Poulton Jeffrey V. Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 8.15K | $0 | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in CRVO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.